Horizon enters into license agreement with Cytovance for HD-BIOP3 Suspension adapted GS null CHO K1 cells Read more
Aptar Pharma Launches PureHale, a New Portable and Ready-to-Use Upper Respiratory Drug Delivery Solution Read more
Pharma Giants Collaboration Accelerates Access to Rare Disease Treatment – Hear more at Orphan Drugs & Rare Diseases 2018 Read more
Dr. Reddy’s Laboratories Announces the Sale of Its Antibiotic Manufacturing Site and Its Related Assets in Bristol, Tennessee Read more
Vertex Announces Access Contract in Denmark for Current and Future Cystic Fibrosis Medicines Read more